Filing Details
- Accession Number:
- 0001225208-17-003623
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-16 18:53:59
- Reporting Period:
- 2017-02-15
- Filing Date:
- 2017-02-16
- Accepted Time:
- 2017-02-16 18:53:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
200406 | Johnson & Johnson | JNJ | Pharmaceutical Preparations (2834) | 221024240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1559387 | Paulus Stoffels | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | Exec Vp, Chief Scientific Off | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-02-15 | 22,000 | $117.29 | 127,650 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $117.23 to $117.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.